OTCMKTS:GNFTF

Genfit News Headlines

$3.81
-0.03 (-0.89 %)
(As of 06/18/2021 09:34 AM ET)
Add
Compare
Today's Range
$3.81
$3.81
50-Day Range
$3.81
$4.65
52-Week Range
$3.75
$6.64
Volume200 shs
Average Volume383 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Genfit (OTCMKTS GNFTF) News Headlines Today

SourceHeadline
Hedge Funds Are Betting On Genfit SA (GNFT)Hedge Funds Are Betting On Genfit SA (GNFT)
finance.yahoo.com - June 18 at 3:47 PM
GENFIT:  June 15, 2021 Combined Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first conveningGENFIT: June 15, 2021 Combined Shareholders Meeting: Wide support for the resolutions submitted to the shareholders’ vote but quorum not met on first convening
finance.yahoo.com - June 15 at 6:33 PM
GENFIT Provides Pipeline Update and Launch of New Clinical ProgramsGENFIT Provides Pipeline Update and Launch of New Clinical Programs
finance.yahoo.com - May 11 at 6:51 PM
GENFIT Annual Combined General Meeting of June 15, 2021 - Availability of Preparatory DocumentsGENFIT Annual Combined General Meeting of June 15, 2021 - Availability of Preparatory Documents
finance.yahoo.com - May 10 at 7:20 PM
GENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered by GENFIT’s NIS4™ Technology to Identify Patients with At-Risk NASHGENFIT announces the launch by Labcorp of NASHnext® A Novel Noninvasive Diagnostic Test Powered by GENFIT’s NIS4™ Technology to Identify Patients with At-Risk NASH
finance.yahoo.com - May 3 at 5:41 AM
GENFIT hires Thomas Baetz as Chief Financial Officer and adds two new members to its Executive CommitteeGENFIT hires Thomas Baetz as Chief Financial Officer and adds two new members to its Executive Committee
finance.yahoo.com - April 22 at 7:47 PM
GENFIT Reports Full-Year 2020 Financial Results and Provides Corporate UpdateGENFIT Reports Full-Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - April 1 at 6:00 PM
GENFIT: 2021 Financial CalendarGENFIT: 2021 Financial Calendar
markets.businessinsider.com - February 13 at 12:10 AM
GENFIT Announces Publication of Positive Results from the Phase 2 Clinical Trial Evaluating Elafibranor in Patients with PBC in the Journal of HepatologyGENFIT Announces Publication of Positive Results from the Phase 2 Clinical Trial Evaluating Elafibranor in Patients with PBC in the Journal of Hepatology
finance.yahoo.com - February 9 at 6:45 PM
GENFIT: New Data Presented at AASLD The Liver Meeting Digital Experience™GENFIT: New Data Presented at AASLD The Liver Meeting Digital Experience™
finance.yahoo.com - November 16 at 6:34 PM
GNFTF Real-Time QuotesGNFTF Real-Time Quotes
nasdaq.com - October 27 at 6:08 PM
Genfit SA (XUP.SG)Genfit SA (XUP.SG)
ca.finance.yahoo.com - October 16 at 7:34 PM
GENFIT S.A. EO -,25 (XUP.MU)GENFIT S.A. EO -,25 (XUP.MU)
ca.finance.yahoo.com - October 16 at 9:33 AM
Genfit SA to Host Earnings CallGenfit SA to Host Earnings Call
baystreet.ca - September 30 at 6:06 PM
Genfit up 47% on NASH test deal with LabCorpGenfit up 47% on NASH test deal with LabCorp
seekingalpha.com - September 28 at 9:23 AM
GENFIT Announces Two Oral Presentations at the Digital International Liver Congress™ 2020GENFIT Announces Two Oral Presentations at the Digital International Liver Congress™ 2020
finance.yahoo.com - August 26 at 5:30 PM
Genfit bails on elafibranor in NASHGenfit bails on elafibranor in NASH
seekingalpha.com - July 22 at 5:55 PM
GENFIT: Provides Initial Update on Corporate StrategyGENFIT: Provides Initial Update on Corporate Strategy
finance.yahoo.com - July 22 at 5:55 PM
GENFIT:  Half-Year Report of Liquidity Contract with Crédit Industriel et CommercialGENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
finance.yahoo.com - July 10 at 4:50 PM
Intercept Shares Tumble on NASH DisappointmentIntercept Shares Tumble on NASH Disappointment
finance.yahoo.com - June 29 at 4:53 PM
After Drug Failure, Genfits Cupboard Is Nearly BareAfter Drug Failure, Genfit's Cupboard Is Nearly Bare
finance.yahoo.com - May 14 at 7:06 PM
GNFT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Genfit SA and Encourages Investors to Contact the FirmGNFT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Genfit SA and Encourages Investors to Contact the Firm
finance.yahoo.com - May 12 at 4:59 PM
Genfit Plunges After Liver Medicine Falls Short in StudyGenfit Plunges After Liver Medicine Falls Short in Study
www.bloomberg.com - May 12 at 4:59 PM
Here's Why Shares of Durect Jumped Higher TodayHere's Why Shares of Durect Jumped Higher Today
finance.yahoo.com - May 12 at 4:59 PM
Why Genfit (GNFT) Stock Might be a Great PickWhy Genfit (GNFT) Stock Might be a Great Pick
finance.yahoo.com - April 17 at 1:12 PM
Genfit SA (EPA:GNFT) Just Released Its Full-Year Earnings: Heres What Analysts ThinkGenfit SA (EPA:GNFT) Just Released Its Full-Year Earnings: Here's What Analysts Think
finance.yahoo.com - April 11 at 7:46 AM
Genfit SA (EPA:GNFT) Just Released Its Full-Year Earnings: Here's What Analysts ThinkGenfit SA (EPA:GNFT) Just Released Its Full-Year Earnings: Here's What Analysts Think
finance.yahoo.com - April 11 at 7:46 AM
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Genfit SA - GNFTSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Genfit SA - GNFT
www.benzinga.com - February 24 at 2:48 PM
Genfit slips 4% on delay of data readout on NASH candidate elafibranorGenfit slips 4% on delay of data readout on NASH candidate elafibranor
seekingalpha.com - February 21 at 1:47 PM
Genfit Delays Data From Liver-Disease Study. Analysts Are Confused and the Stock Is Falling.Genfit Delays Data From Liver-Disease Study. Analysts Are Confused and the Stock Is Falling.
www.barrons.com - February 21 at 1:47 PM
BRIEF-Genfit SA Says Unblinding Of Phase 3 Resolve-It Data Will Incorporate Latest FDA InsightsBRIEF-Genfit SA Says Unblinding Of Phase 3 Resolve-It Data Will Incorporate Latest FDA Insights
uk.reuters.com - February 20 at 11:40 PM
Is Genfit SA (EPA:GNFT) A Volatile Stock?Is Genfit SA (EPA:GNFT) A Volatile Stock?
finance.yahoo.com - November 18 at 5:45 AM
Genfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical OfficerGenfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer
finance.yahoo.com - September 9 at 8:32 AM
GENFIT: FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC)GENFIT: FDA and EMA Grant GENFIT’s Elafibranor Orphan Drug Designation for Primary Biliary Cholangitis (PBC)
finance.yahoo.com - July 29 at 8:28 AM
GENFIT: GENFIT and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater ChinaGENFIT: GENFIT and Terns Pharmaceuticals Announce $228MM Strategic Partnership to Develop and Commercialize Elafibranor in Greater China
finance.yahoo.com - June 24 at 5:45 PM
Terns Pharmaceuticals Announces Exclusive Licensing and Collaboration Agreement with GENFIT to Develop and Commercialize Elafibranor in the Greater China RegionTerns Pharmaceuticals Announces Exclusive Licensing and Collaboration Agreement with GENFIT to Develop and Commercialize Elafibranor in the Greater China Region
finance.yahoo.com - June 24 at 5:45 PM
GENFIT: Outcome of the Ordinary Shareholder’s Meeting of June 13, 2019GENFIT: Outcome of the Ordinary Shareholder’s Meeting of June 13, 2019
finance.yahoo.com - June 13 at 5:49 PM
Genfit: GENFIT Launches a Phase 2 Trial Evaluating Elafibranor on Hepatic Lipid Composition for NAFLGenfit: GENFIT Launches a Phase 2 Trial Evaluating Elafibranor on Hepatic Lipid Composition for NAFL
finance.yahoo.com - June 4 at 5:40 PM
Genfit: GENFIT Launches a Combination Therapy Clinical Program in NASHGenfit: GENFIT Launches a Combination Therapy Clinical Program in NASH
finance.yahoo.com - May 23 at 6:02 PM
Can This NASH Stock Really Double Your Money?Can This NASH Stock Really Double Your Money?
finance.yahoo.com - April 24 at 9:49 AM
Genfit: GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary SharesGenfit: GENFIT Announces Closing of Global Offering and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
finance.yahoo.com - March 29 at 5:59 PM
Biotech Has Gotten Crowded, but There’s Plenty of Room for Genfit, Exec SaysBiotech Has Gotten Crowded, but There’s Plenty of Room for Genfit, Exec Says
finance.yahoo.com - March 29 at 10:03 AM
Genfit: GENFIT Announces the Exercise in Full of the Option Granted to the Underwriters of its Global Offering and Nasdaq Global Select Market Listing to Purchase up to 997,500 Additional ADSsGenfit: GENFIT Announces the Exercise in Full of the Option Granted to the Underwriters of its Global Offering and Nasdaq Global Select Market Listing to Purchase up to 997,500 Additional ADSs
finance.yahoo.com - March 28 at 5:51 PM
Genfit: GENFIT ANNOUNCES TRADING HALT OF ITS SHARES AND OF ITS OCEANES ON EURONEXT PARIS AND EURONEXT ACCESSGenfit: GENFIT ANNOUNCES TRADING HALT OF ITS SHARES AND OF ITS OCEANES ON EURONEXT PARIS AND EURONEXT ACCESS
finance.yahoo.com - March 27 at 10:21 AM
Genfit: GENFIT ANNOUNCES TRADING RESUMPTION OF ITS SHARES AND OF ITS OCEANES ON EURONEXT PARIS AND EURONEXT ACCESSGenfit: GENFIT ANNOUNCES TRADING RESUMPTION OF ITS SHARES AND OF ITS OCEANES ON EURONEXT PARIS AND EURONEXT ACCESS
finance.yahoo.com - March 27 at 10:21 AM
Genfit files for IPOGenfit files for IPO
seekingalpha.com - March 14 at 5:59 PM
GENFIT Announces Launch of Proposed Global Offering and Nasdaq ListingGENFIT Announces Launch of Proposed Global Offering and Nasdaq Listing
finance.yahoo.com - March 14 at 5:59 PM
GENFIT Announces FDA Protocol Clearance for Phase 2 Clinical Trial of Elafibranor in Pediatric NASHGENFIT Announces FDA Protocol Clearance for Phase 2 Clinical Trial of Elafibranor in Pediatric NASH
finance.yahoo.com - March 11 at 10:39 AM
Genfit In NASH And Market Assessment: Whats New?Genfit In NASH And Market Assessment: What's New?
seekingalpha.com - March 8 at 6:04 PM
Genfit May Become Very Interesting By The End Of 2019Genfit May Become Very Interesting By The End Of 2019
seekingalpha.com - March 2 at 9:31 AM
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.